3649 related articles for article (PubMed ID: 10362250)
61. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
[TBL] [Abstract][Full Text] [Related]
62. Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory molecules.
Hsu SL; Hsieh YC; Hsieh WC; Chou CJ
Eur J Pharmacol; 2001 Aug; 425(3):165-71. PubMed ID: 11513834
[TBL] [Abstract][Full Text] [Related]
63. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
Parry D; Mahony D; Wills K; Lees E
Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
[TBL] [Abstract][Full Text] [Related]
64. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
Calbó J; Serna C; Garriga J; Graña X; Mazo A
Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
[TBL] [Abstract][Full Text] [Related]
65. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
[TBL] [Abstract][Full Text] [Related]
66. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
Gray-Bablin J; Rao S; Keyomarsi K
Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
[TBL] [Abstract][Full Text] [Related]
67. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
68. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
69. Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium.
Robson CN; Gnanapragasam V; Byrne RL; Collins AT; Neal DE
J Endocrinol; 1999 Feb; 160(2):257-66. PubMed ID: 9924195
[TBL] [Abstract][Full Text] [Related]
70. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
71. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
Iavarone A; Massagué J
Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
[TBL] [Abstract][Full Text] [Related]
72. Non-malignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrest.
Donovan JC; Rothenstein JM; Slingerland JM
J Biol Chem; 2002 Nov; 277(44):41686-92. PubMed ID: 12202478
[TBL] [Abstract][Full Text] [Related]
73. TGF-beta1-mediated hypertrophy involves inhibiting pRB phosphorylation by blocking activation of cyclin E kinase.
Liu B; Preisig P
Am J Physiol; 1999 Aug; 277(2):F186-94. PubMed ID: 10444572
[TBL] [Abstract][Full Text] [Related]
74. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.
Cheng L; Rossi F; Fang W; Mori T; Cobrinik D
J Biol Chem; 2000 Sep; 275(39):30317-25. PubMed ID: 10906146
[TBL] [Abstract][Full Text] [Related]
75. Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.
Hu X; Zuckerman KS
Leuk Lymphoma; 2000 Jul; 38(3-4):235-46. PubMed ID: 10830731
[TBL] [Abstract][Full Text] [Related]
76. Cyclin E-CDK2 is a regulator of p27Kip1.
Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
[TBL] [Abstract][Full Text] [Related]
77. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
Lepley DM; Pelling JC
Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954
[TBL] [Abstract][Full Text] [Related]
78. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein.
Herrera RE; Mäkelä TP; Weinberg RA
Mol Biol Cell; 1996 Sep; 7(9):1335-42. PubMed ID: 8885230
[TBL] [Abstract][Full Text] [Related]
79. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
80. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.
Alexander K; Hinds PW
Mol Cell Biol; 2001 Jun; 21(11):3616-31. PubMed ID: 11340156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]